Skip to content Skip to footer

Privacy Policy

This privacy policy discloses the privacy practices for Rejuva Research. This privacy policy applies solely to information collected by this website. It will notify you of the following:

  • What personally identifiable information is collected from you through the website, how it is used, and with whom it may be shared.
  • What choices are available to you regarding the use of your data.
  • The security procedures in place to protect against the misuse of your information.
  • How you can correct any inaccuracies in the information.

Information Collection, Use, and Sharing

We are the sole owners of the information collected on this site. We only have access to/collect information that you voluntarily give us via email or another direct contact from you.

Unless you ask us not to, we may contact you via email in the future to tell you about specials, new products or services, or changes to this privacy policy.

Your Access to and Control Over Information

You may opt-out of any future contacts from us at any time. You can do the following at any time by contacting us via the email address or phone number given on our website:

  • See what data we have about you if any.
  • Change/correct any data we have about you.
  • Have us delete any data we have about you.
  • Express any concern you have about our use of your data.

Security

We take precautions to protect your information. When you submit sensitive information via the website, your information is protected both online and offline.

Wherever we collect sensitive information (such as credit card data), that information is encrypted and transmitted to us in a secure way. You can verify this by looking for a closed lock icon at the bottom of your web browser, or looking for “https” at the beginning of the address of the web page.

While we use encryption to protect sensitive information transmitted online, we also protect your information offline. Only employees who need the information to perform a specific job (for example, billing or customer service) are granted access to personally identifiable information. The computers/servers in which we store personally identifiable information are kept in a secure environment in Canada.

Rejuva Research practices in accordance with all providentially and federally applicable legislation. Additionally, we follow the industry’s best practices in regard to safety and security.

Risks of using digital communications

  1. The information could be requested, viewed, changed, or deleted if others are allowed access to your phone, tablet, or email account.
  2. Information may be vulnerable if stored on a computer/device that has been compromised by viruses or malware.
  3. Organizations may have to disclose information where required by law or under court order.
  4. Electronic communications can be intercepted by third parties.

Updates

Our Privacy Policy may change from time to time and all updates will be posted on this page.

If you feel that we are not abiding by this privacy policy, you should contact us immediately via email info@coalharbourhealth.ca

Medical Cannabis Release

I agree not to make any claim or complaint or commence any proceedings against any Rejuva Research physician and/or the Rejuva Research’s staff in relation to the application process under The Cannabis Act and its regulations or my use of cannabis.

I release the Rejuva Research’s physician and staff from any or all actions, causes of actions, claims, complaints, and demands for damages, loss, or injury, whatsoever arising directly or indirectly as a consequence of my application under The Cannabis Act or my use of cannabis. This release from liability is to be binding on my heirs, executors, and assigns.

Informed Consent

In the event that the company proceeds with the reorganization, sale, lease, merger or amalgamation or any other type of disposal or financing of the company or a portion of the company or of any of the business or assets of the company, the company shall comply with the requirements set out in subsection 20(3) of the Personal Information Protection Act (British Columbia).

The company may collect, use, share and access different types of information or data about the company’s clients and/or patients in such ways that do not identify such individuals directly (e.g. by name) or indirectly (e.g. by date of birth) and for statistical purposes only. Such information may include personal characteristics or other information about which an individual has a reasonable expectation of privacy (e.g., age, ethnicity, health history, life experience, social status). The company does not release any information that could identify individuals without their consent. The company covenants that all personal information (within the meaning attributed thereto in applicable legislation in British Columbia) of or with respect to the patients shall only be used, disclosed or dealt with in strict compliance with applicable privacy legislation.

Who has Access to Information Collected?

We strictly control access to your personal information to our employees who need this information in order to serve you or to employees who analyze our performance in order to measure and improve our services. Employees are kept up-to date with regard to the privacy and security practices of Rejuva Research.

We reserve the right to co-operate with local, provincial and national officials in any investigation requiring either personal information including any personal information provided online or reports about lawful and unlawful user activities on the Web site.

If you ask us, we will remove any information about you from our files, unless some legitimate purpose makes its reasonable for us to retain it for some additional time. We will also review our files from time to time with a view to identifying and deleting stale information.

Risks of using electronic communication

Rejuva Research has offered to communicate using the following means of electronic communication (“the Services”): Email, VideoConferencing, Text messaging

Rejuva Research will use reasonable means to protect the security and confidentiality of information sent and received using the Services. However, because of the risks outlined below, the Physician cannot guarantee the security and confidentiality of electronic communications:

Use of electronic communications to discuss sensitive information can increase the risk of such information being disclosed to third parties. Despite reasonable efforts to protect the privacy and security of electronic communication, it is not possible to completely secure the information.

Employers and online services may have a legal right to inspect and keep electronic communications that pass through their system.

Electronic communications can introduce malware into a computer system, and potentially damage or disrupt the computer, networks, and security settings.

Electronic communications can be forwarded, intercepted, circulated, stored, or even changed without the knowledge or permission of the Physician or the patient.

Even after the sender and recipient have deleted copies of electronic communications, back-up copies may exist on a computer system.

Electronic communications may be disclosed in accordance with a duty to report or a court order.

Videoconferencing using services such as VSee or Zoom may be more open to interception than other forms of videoconferencing.

Email, text messages, and instant messages can more easily be misdirected, resulting in increased risk of being received by unintended and unknown recipients.

INFORMED CONSENT

By signing this document, you acknowledge that you have been informed of and understand the following:

The physicians, the clinic staff, and/or clinic representatives are neither providing nor dispensing the medical cannabis.

The physician or clinic staff will NOT be providing or discussing information regarding any other way of obtaining medical cannabis other than from a Health Canada approved licensed producer.

The physicians are evaulating you for the use of medical cannabis and will make their recommendation based in part, on the medical information you have provided. It is your responsibility to ensure that there is no misrepresentation of your medical information submitted in order for you to obtain a recommendation to use cannabis for your medical condition.

You agree to only use medical cannabis for the treatment of your medical condition as agreed upon by the physician and not for recreational or non-medical purposes.

The physician is addressing specific aspects of your medical care and, unless otherwise stated, is in no way establishing herself as your primary care physician.

Should the physician approve you for the use of medical cannabis, it is your responsibility to ensure that a renewal appointment is made one month prior to your expiry date. During your renewal appointment the physician will re-evaulate the possible continuance of cannabis.

You understand that it is your responsibility to stay informed regarding provincial and federal laws regarding the possession, use, sale/purchase and/or distribution of medical cannabis.

Health Canada, the physicians and the Rejuva Research staff advise you that using cannabis is prohibited while driving or performing hazardous tasks such as operating heavy machinery. The same applies to safety-sensitive occupations such as health professionals and the supervision of children. Depending on dosage and administration, impairment can last over 24 hours following last usage.

The potential side effects from the use of cannabis include, but are not limited to the following; dizziness, anxiety, confusion, sedation, low blood pressure, impairment of short-term memory, euphoria, difficulty in completing complex tasks, suppression of the body’s immune system, inability to concentrate, impaired motor skills, paranoia, psychotic symptoms, general apathy, depression and/or restlessness.

Cannabis may exacerbate schizophrenia in persons predisposed to the disorder.

Cannabis use may cause exessive talking and eating, alter your perception of time and space and impair your judgement.

You understand that using cannabis while under the influence of alcohol is not recommended. Additional side effects may become present when using both alcohol and cannabis.

Smoking cannabis may cause respiratory problems and harm, including; bronchitis, emphysema and laryngitis. In the opinion of many researchers, cannabis smoke contains known carcinogens (chemicals that cause cancer) and smoking cannabis may increase the risk of respiratory diseases and cancers in the lung, mouth, and tongue. In addition, cannabis smoke contains harmful chemicals known as tars. If you begin to experience respiratory problems when using cannabis, you agree to stop using it and report your symptoms to a physician.

The physicians and/or the Rejuva Research staff will inform you of alternatives to smoking cannabis.

The risk, benefits and drug interactions of cannabis are not fully understood. If you are taking medication or undergoing treatment for any medical condition, you understand that you should consult with your primary care physician(s) before using cannabis and that you should not discontinue and medication or treatment previously prescribed unless advised to do so by your primary care physician.

Individuals may develop a tolerance to and/or dependence on cannabis. If you develop signs of withdrawal, which can include; feelings of depression, sadness, irritability, insomnia, restlessness, agitation, loss of appetite, trouble concentrating, sleep disturbances, and unusual tiredness, contact the Rejuva Research.

Symptoms of cannabis overdose include but are not limited to; nausea, vomiting, hacking cough, disturbance in heart rhythm, numbness in hands, feet, arms or legs, anxiety attacks and incapacitation. If you experience these symptoms, you agree to contact your primary care physician, call 911 or go to the nearest emergency room.

If the Rejuva Research subsequently learns that the information you have furnished is false or misleading, the recommendation by the physician for cannabis may be revoked. You agree to promptly meet the Rejuva Research and/or provide additional information in the event of any inaccuracies or misstatements in the information you have provided.

Recommendations made by the Rejuva Research about Licensed Producers, strains and methods of intake are recommendations ONLY. The Rejuva Research reserves the the right to discuss your information with your licensed producer and you agree with your licensed producer sharing information about your application and recommendation with the Rejuva Research.

If you do not understand any of the above, you agree to contact the Rejuva Research for clarification.

The Rejuva Research is a private clinic that charges a fee for service. The clinic has a 7 day cancellation policy. Failure to cancel your appointment within the 7 days will result in a $200.00 charge. To cancel an appointment, you must speak directly with one of the clinics medical office assistants. Cancellations by email or phone message will not be accepted.

I authorize any Rejuva Research physician to make direct contact with a current, treating primary care physician to determine whether excessive use of cannabis has harmed myself, the patient.

I understand that the information I have been asked to provide to the Rejuva Research and/or the Physician is for the diagnosis and treatment of the medical condition(s) for which I want to access medical cannabis. I understand that if I have not accurately and completely disclosed the requested information, it may adversely impact the physician’s ability to diagnose my condition and recommend appropriate medical cannabis treatment.

Treatment Agreement

Because we take our responsibilities to authorize and supervise the medical use of cannabis very seriously, we require you to read and understand this form before applying.

I have been made aware that cannabis laws vary in other countries and may be illegal, therefore patients Licensed Producer cannabis products should not be taken outside of Canada.

I request a Rejuva Research physician to sign a medical document for me under the Health Canada ACMPR legislation, so that I may legally use cannabis to treat my medical condition.

I agree to receive a medical document for cannabis only from ONE physician

I agree to consume no more cannabis than the amount authorized for me by a Rejuva Research physician.

I understand that the distribution, sharing, or sale of my cannabis with any other party is against the law.

I agree to the safe storage of my cannabis.

I am aware that taking cannabis with other substances, especially sedating substances, may cause harm and possibly even death. I will not use controlled substances that were prescribed by another doctor unless my Rejuva Research physician is aware of this.

I agree to test (eg. urine drug screening) when requested by my physician.

I understand that Health Canada has provided access to cannabis by a signed medical documents from a physician for the treatment of certain medical conditions, but despite this, Health Canada has not approved cannabis as a registered medication in Canada. I understand that my physician may not be knowledgeable about all of the risks associated with the use of a non-Health Canada approved substance like cannabis.

I agree to communicate to my Rejuva Research physician, any experiences of altered mental status or possible medical side effects of the use of cannabis. I accept full responsibility for any and all risks associated with the use of cannabis. I am aware that my physician may discontinue authorizing cannabis for my condition if the medical or mental health risk or side effects are found to be unsafe.

I am aware that cannabis use is not advisable during pregnancy and breastfeeding. I agree to inform my Rejuva Research Clinic physician if I am pregnant.

I am aware that smoking any substance can cause harm and medical complications to my breathing. I will avoid smoking cannabis. I will avoid mixing cannabis with tobacco. I agree to use my cannabis only by a vaporizer or as an edible product.

I understand that cannabis may alter my ability to drive safely or make important decisions. I agree to avoid driving, operating machinery important decisions, or activity alike for at least:

4 hours after inhalation

6 hours after ingestion of oils or edibles

8 hours after any feeling of euphoria

longer than 8 hours if I feel intoxicated

As per the Health Canada ACMPR legislation, I agree to purchase my cannabis only from a licensed producer. I am aware that possession of cannabis from other sources is illegal.

Rejuva Research has the right to contact my licensed producer to obtain a printed history of my cannabis purchases.

Following the terms of this contract is one of the conditions I must meet to access cannabis for treatment. I understand that if violated, my physician may stop authorizing the use of cannabis.

It is the patient’s responsibility to ensure that their authorization is renewed with a Rejuva Research physician one month prior to the expiry date. For patients who are cultivating their own medication, renewal should be done 4 months prior to expiry due to Health Canada wait times.

It is the patient’s responsibility to ensure that all product is kept in the original packaging from their Licensed Producer. If cultivating their own medication, a copy of the Health Canada issued license, should be kept in their wallet.